Brexucabtagene Autoleucel,Axicabtagene Ciloleucel,Cyclophosphamide,Fludarabine
Gilead
['brexu-cel', 'kitepharma']
icymi: ahmed noted that the overall response rate (orr) for 's brexu-cel in the real-world study cohort was 90% and the complete response (cr) rate was 78%. #eha2023 watch now: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.